Skip to content
Open access

Alpha-synuclein and neuromelanin converge to promote Parkinson’s disease pathology

Oct 2026 · bioRxiv · 0 citations · 69 references
Biology

Abstract

Parkinson’s disease (PD) is defined by the preferential degeneration of neuromelanin (NM)-containing dopamine-producing neurons in the substantia nigra (SN), accompanied by intraneuronal inclusions rich in alpha-synuclein (αSYN). However, the mechanistic relationship between NM accumulation and αSYN pathology remains unclear. Here, we reveal a bidirectional pathogenic relationship between αSYN and NM. In human post-mortem midbrain tissue, ventral nigral neurons with high NM content display increased αSYN mRNA expression and are preferentially lost in PD. In a rat model that recapitulates age-dependent, human-like NM accumulation via targeted tyrosinase (TYR) expression, co-expression of αSYN accelerates NM buildup, enhances αSYN oligomerization, and aggravates nigrostriatal degeneration. Mechanistically, αSYN oligomerization in NM-producing rats decreases vesicular dopamine storage and impairs vesicle fusion with the plasma membrane, increasing cytosolic dopamine availability for oxidation into NM. Together, these findings support a pathogenic feedback loop in which elevated αSYN accelerates NM synthesis through disrupted dopamine compartmentalization, while NM accumulation further promotes αSYN aggregation and neuronal loss. This αSYN-NM axis may underlie the preferential vulnerability of pigmented nigral neurons in PD and provide a mechanistic framework for the development of future targeted therapeutics.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.